The compelling need for a cardiology and oncology partnership and the birth of the International CardiOncology Society
- PMID: 20728695
- DOI: 10.1016/j.pcad.2010.06.002
The compelling need for a cardiology and oncology partnership and the birth of the International CardiOncology Society
Abstract
Cardiac disease in patients with cancer is common and influences the longevity and quality of life both of patients in active treatment and of survivors of cancer. The disciplines of cardiology and oncology have increasingly recognized the benefits to patients of collaborating in the care of cancer patients with cardiac disease. This increased recognition arises from several factors: the aging population in which both cardiac and cancer diagnoses are common; the cellular and molecular therapeutic targets of newer medical treatments, and, in particular, the specific patient treatment choices and decisions that require careful, effective clinical interactions between these 2 disciplines. Responding to this need for an effective partnership between cardiology and oncology, the International CardiOncology Society was created and has set goals to develop and enhance our understanding and management of these clinical difficulties.
Copyright 2010 Elsevier Inc. All rights reserved.
Similar articles
-
Developing a cardiology-oncology clinical practice guideline.Prog Cardiovasc Dis. 2010 Sep-Oct;53(2):173-9. doi: 10.1016/j.pcad.2010.06.001. Prog Cardiovasc Dis. 2010. PMID: 20728705 Review.
-
Cardiac disease in cancer patients: an overview.Prog Cardiovasc Dis. 2010 Sep-Oct;53(2):80-7. doi: 10.1016/j.pcad.2010.05.004. Prog Cardiovasc Dis. 2010. PMID: 20728694 No abstract available.
-
Interventional strategies to manage heart failure in patients with cancer.Heart Fail Clin. 2011 Jul;7(3):395-402. doi: 10.1016/j.hfc.2011.03.010. Epub 2011 May 14. Heart Fail Clin. 2011. PMID: 21749891 Review.
-
Cardiac toxicity from systemic cancer therapy: a comprehensive review.Prog Cardiovasc Dis. 2010 Sep-Oct;53(2):94-104. doi: 10.1016/j.pcad.2010.05.006. Prog Cardiovasc Dis. 2010. PMID: 20728696 Review.
-
Cardio-Oncology Programs Strive to Balance Cancer Care With Heart Health.Circulation. 2016 Jul 26;134(4):353-4. doi: 10.1161/CIRCULATIONAHA.116.024094. Circulation. 2016. PMID: 27462055 No abstract available.
Cited by
-
Proceedings From the Global Cardio-Oncology Summit: The Top 10 Priorities to Actualize for CardioOncology.JACC CardioOncol. 2019 Dec 17;1(2):256-272. doi: 10.1016/j.jaccao.2019.11.007. eCollection 2019 Dec. JACC CardioOncol. 2019. PMID: 34396188 Free PMC article. Review.
-
Asymptomatic cardiac toxicity in long-term cancer survivors: defining the population and recommendations for surveillance.Semin Oncol. 2013 Apr;40(2):229-38. doi: 10.1053/j.seminoncol.2013.01.005. Semin Oncol. 2013. PMID: 23540748 Free PMC article.
-
Hypertension management in cardio-oncology.J Hum Hypertens. 2020 Oct;34(10):673-681. doi: 10.1038/s41371-020-0391-8. Epub 2020 Aug 3. J Hum Hypertens. 2020. PMID: 32747676 Free PMC article. Review.
-
Cardio-oncology Related to Heart Failure: Common Risk Factors Between Cancer and Cardiovascular Disease.Heart Fail Clin. 2017 Apr;13(2):367-380. doi: 10.1016/j.hfc.2016.12.006. Heart Fail Clin. 2017. PMID: 28279422 Free PMC article. Review.
-
Cancer and Cardiovascular Disease: The Complex Labyrinth.J Oncol. 2015;2015:516450. doi: 10.1155/2015/516450. Epub 2015 Aug 4. J Oncol. 2015. PMID: 26345724 Free PMC article. No abstract available.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
